Updated: Nov 7, 2024
The average Biomarin Pharmaceutical stock price target is 99.64 with a max estimate of 139.00 and a min estimate of 72.00
Review Biomarin Pharmaceutical earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Nov 7, 2024
No Data